Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.97 |
| ▸ | MEN1 | O00255 | 1/20 | 0.97 |
| ▸ | RGS12 | O14924 | 1/20 | 0.97 |
| ▸ | NPC1 | O15118 | 1/20 | 0.97 |
| ▸ | USP2 | O75604 | 1/20 | 0.97 |
| ▸ | LMNA | P02545 | 1/20 | 0.97 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.97 |
| ▸ | THRB | P10828 | 1/20 | 0.97 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.97 |
| ▸ | HTT | P42858 | 1/20 | 0.97 |
| ▸ | RAD52 | P43351 | 1/20 | 0.97 |
| ▸ | RAB9A | P51151 | 1/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.97 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.97 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.97 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.97 |
| ▸ | BCHE | P06276 | 13/20 | 0.82 |
| ▸ | ACHE | P22303 | 13/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9319117 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL4068375 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL1963218 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL29721510 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL4061564 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL4071951 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL1412685 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| SCHEMBL1412766 | 1.00 | KDM4E (0.97) | KDM4EMEN1RGS12NPC1USP2 | |
| Bromide SCHEMBL3359102 | 0.98 | KDM4E (0.93) | KDM4EMEN1RGS12NPC1USP2 | |
| Hydrochloric Acid SCHEMBL780409 | 0.98 | KDM4E (0.93) | KDM4EMEN1RGS12NPC1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110144079-A1 | ANTIMICROBIAL SYSTEM | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2011-06-16 | — | — | US | claimed |
| US-20110144079-A1 | ANTIMICROBIAL SYSTEM | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2011-06-16 | — | — | US | disclosed |
| WO-2009040107-A2 | METHOD FOR THE PRODUCTION OF METAL-CONTAINING NANOPARTICLES | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009024312-A2 | METHOD FOR THE PRODUCTION AND STABILIZATION OF FUNCTIONAL METAL NANOPARTICLES IN IONIC LIQUIDS | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-02-26 | — | — | WO | disclosed |
| EP-0340421-B1 | Conducting varnish composition | NITTO CHEMICAL INDUSTRY CO LTD (JP) | 1993-11-10 | — | — | EP | disclosed |
| US-5009811-A | Containing tetracyanoquinodimethan complex salts, thermo-plastic polymers, acetals, ortho acid esters, disiloxanes, silyl esters and acids, solvent and surfactants | NITTO CHEMICAL INDUSTRY COMPANY, LTD. (JP) | 1991-04-23 | — | — | US | disclosed |
| EP-0340421-A2 | Conducting varnish composition | NITTO CHEMICAL INDUSTRY CO., LTD. (JP) | 1989-11-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144079-A1 | ANTIMICROBIAL SYSTEM | PIK3C3, POLR1C, LTN1 | KDM4E 3065/4885MEN1 4090/4885RGS12 2540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.